ANPEP and lung adenocarcinoma: Another study has shown that the migration capacity of human lung adenocarcinoma cells expressing a genetically modified, enzymatically inactive form of CD13 is not fully impaired, suggesting that CD13 can enhance cancer cell motility by both enzyme-dependent and enzyme-independent mechanisms [42].